期刊文献+

HPLC法测定地氯雷他定片的含量 被引量:4

Determination of Desloratadine Tablets by HPLC
下载PDF
导出
摘要 目的采用HPLC法测定地氯雷他定片含量。方法 Agilent Eclipse XDB-C18色谱柱(4.6 mm×150 mm,5μm),以甲醇-10 mmol/L磷酸二氢钾(50∶50)为流动相,流速:1.0 ml/min,检测波长:241 nm,进样量:20μl。结果地氯雷他定在12.5~125μg/ml范围内线性关系良好(r=0.9999),平均回收率为98.7%。结论本方法精密度好,结果准确、可靠、灵敏,可用于地氯雷他定片的含量测定。 Objective To develop a method for determination of desloratadine by HPLC.Methods Chromatography was performed on Agilent Eclipse XDB-C18 column(4.6 mm×150 mm,5 μm),with methanol and phosphate buffer(50∶ 50)as the mobile phase at a flow rate of 1.0 ml/min.The absorbance was monitored at 241 nm.The injection volume was 20 μl.Results The calibration curve of desloratadine was linear within the range of 12.5-125 μg/ml(r=0.9999).The recovery was 98.7%.Conclusion This method is accurate,reliable and sensitive.It can be used for quality control of desloratadine tablets.
出处 《解放军药学学报》 CAS 2012年第1期63-64,共2页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 HPLC 地氯雷他定 含量测定 HPLC desloratadine determination
  • 相关文献

参考文献4

二级参考文献20

  • 1薛建英,陈泠,谭国良,张瑞华,陈国良.抗过敏药盐酸奥洛他定的合成工艺研究[J].中国药物化学杂志,2004,14(6):363-364. 被引量:6
  • 2卢晓阳,申屠建中,陈志根,黄明珠,周慧丽,郑国钢.液质联用测定血清中地氯雷他定及人体药动学研究[J].浙江大学学报(医学版),2005,34(4):372-374. 被引量:3
  • 3谌叶香,邹健军,龚厚军,李妩真,杨泽英,肖大伟.地洛他定胶囊人体药动学和生物等效性评价[J].中国医院药学杂志,2005,25(8):699-702. 被引量:2
  • 4刘林林,许剑安,储楠楠,陈伟力,徐红蓉,李雪宁.LC-MS/MS法测定人血浆中地氯雷他定及其代谢产物3-羟基地氯雷他定的浓度[J].药物分析杂志,2007,27(6):805-808. 被引量:4
  • 5YANG LY, CLEMENT RP, KANTESARIA B, et al. Validation of a sensitive and automated 96-well solid-phase extraction liquid chromatography-tandem mass spectrometry method for the determintion of desloratadine and 3-hydroxydesloratadine in human plas-ma[J]. J Chromatogr B, 2003, 792(2) : 229-240.
  • 6SHEN JX, WANG HP, TADROS S, et al. Orthogonal extraction/chromatography and UPLC, two powerful new techniques for bio-analytical quantitation of desloratadine and 3- hydroxydeslorata-dine at 25 pg/mL [J]. J Pharm Biomed Anal, 2006, 40(3) : 689-706.
  • 7Juhlin L. Inhibition of cold urticaria by desloratadine[ J]. J Dermatol Treat, 2004,15( 1 ) :51 - 59,.
  • 8Ten Eick AP, Blumer JL, Reed MD. Safety of antihistamines in children[J]. Drug Saf, 2001,24(2) : 119 - 147.
  • 9Anthes JC, Richard C, West RE, et al. Functional characterization of desloratadine and other antihistamines in humane H1 receptors [J].Allergy, 2000,55 ( Suppl 63 ) : S279.
  • 10Lippert U, Moiler A, welker P, et al. Inhibition of cytokine secretion from human leukemic mast cells and basophilis by H1 and H2 receptor antagonists[J]. Exp Dermatol,2000,9(2) : 118 - 124.

共引文献63

同被引文献12

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部